Navigation Links
Chimerix Names George Painter, Ph.D., Chairman of the Board and Chief Scientific Officer; Appoints Kenneth I. Moch President and Chief Executive Officer
Date:5/4/2010

RESEARCH TRIANGLE PARK, N.C., May 4 /PRNewswire/ -- Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced today that Kenneth I. Moch has been appointed President and Chief Executive Officer.  Mr. Moch joined Chimerix as Chief Operating Officer in July 2009, bringing more than 25 years of experience in creating, managing and financing biomedical companies.  Mr. Moch will also join the company's Board, for a total of six directors.  

George Painter, Ph.D., Chimerix's former President and Chief Executive Officer, has been named Chief Scientific Officer and Chairman of the company's Board. In his new role, Dr. Painter will oversee Chimerix's drug discovery and development efforts and seek opportunities to leverage the company's proprietary platform capabilities and antiviral expertise in the advancement of important new medicines that address global health needs.  Seth Rudnick, M.D., General Partner, Canaan Partners and Tim Wollaeger, Managing Director, Sanderling Ventures, formerly Co-Chairmen of the Chimerix Board, remain Directors of the company.    

"Ken Moch and George Painter make an outstanding and highly complementary leadership team.  Ken and George will each play to their strengths in pursuing the same goal:  advancing important antiviral medicines that can save lives," said Mr. Wollaeger on behalf of the Chimerix Board.  "Dr. Painter is a world-class innovator and drug developer and his vision has resulted in the discovery and early evaluation of Chimerix's pipeline of powerful antivirals to address such serious viruses as cytomegaloviru
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Chimerix Appoints Neil Frazer, M.B., Ch.B., FRCA, FFPM as Chief Medical Officer
2. Merial to Screen Chimerix Chemical Library for Animal Health Drug Leads
3. Chimerix Completes Phase I Study and Initiates a Phase II Multi-dose Clinical Trial for CMX001
4. Chimerix Joins International Network of Organizations to Cure Malaria
5. Chimerix, Inc. Appoints Kenneth I. Moch Chief Operating Officer
6. Chimerix Names Wendy Painter, M.D., M.P.H., as Chief Medical Officer
7. KGI Names Kerry Howell Vice President for Advancement
8. Vical Names Andrew de Guttadauro Vice President, Corporate Development
9. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
10. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
11. CryoLife Names Philip Theodore as Vice President, General Counsel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... CANTON, Mass. and NEW ORLEANS ... commercial leader in the field of regenerative medicine, presented ... expert economists from Analysis Group (a leading health economics ... that diabetic foot ulcers (DFU) and venous leg ulcers ... The results of this research, which reveal annual ...
(Date:5/22/2013)... 2013 Mold remediation could take a toll ... is a way to cut down the process' expense. And ... post the details of a method how to kill ... could be prevented, My Cleaning Products said. But in case ... a mold remediation must then be promptly implemented as it ...
(Date:5/22/2013)... May 22, 2013 A recent study from ... on athletes to find that those who took probiotics were ... results from the study showed that in extreme heat conditions, ... for their adult acne treatment explains what this ... it may help their skin condition. , While researchers ...
(Date:5/21/2013)... , May 21, 2013  On May 9, ... ), the global business advisory firm dedicated to ... (the "Company"), announced that it has combined the ... formerly included within the Corporate Finance/Restructuring segment with ... to form a single integrated practice whose financial ...
Breaking Biology Technology:Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 4How to Kill Mold While Saving Thousands of Dollars on Mold Remediation Projects Explained by My Cleaning Products 2Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers 2FTI Consulting Releases Realigned Segment Information Reflecting Newly Combined Health Solutions Practice 2
... /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq:,ONTY) (TSX: ONY) (the "Company") ... per basic and diluted share for the quarter ended ... basic and diluted share for the,comparable period in 2007. ... was $2.0 million in the first quarter of 2008, ...
... PITTSBURGH, May 7 Mylan Inc. (NYSE: MYL ... approval,from the U.S. Food and Drug Administration (FDA) for ... 0.25 mg,(base), 0.5 mg (base), 1 mg (base), 2 ... mg (base)., Ropinirole Hydrochloride Tablets are the generic ...
... $17 ... Million, TUCSON, Ariz., ... it has signed a letter of intent in,which Microbix Biosystems will acquire ... is an FDA-approved,thrombolytic, or clot-dissolving agent, indicated for the treatment of,acute massive ...
Cached Biology Technology:Oncothyreon Reports First Quarter 2008 Financial Results 2Oncothyreon Reports First Quarter 2008 Financial Results 3Oncothyreon Reports First Quarter 2008 Financial Results 4Oncothyreon Reports First Quarter 2008 Financial Results 5ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase 2ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase 3ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase 4
(Date:5/21/2013)... for a long time that some creatures evolve more ... for plants. But it may be that height plays ... and the U. S. National Evolutionary Synthesis Center. ... in the journal Nature Communications , Lanfear and ... Drawing from a database of global patterns in plant ...
(Date:5/21/2013)... in the body, stem cells in the blood ... into mature immune cells that can fight off ... these cell populations, potentially leading to the development ... a team of researchers led by biologists at ... that, in mouse models, the molecule microRNA-146a (miR-146a) ...
(Date:5/21/2013)... ANN ARBORThe new University of Michigan Water Center ... to support Great Lakes restoration and protection efforts. ... will support diverse projects, including efforts to track ... effectiveness of techniques to control non-native weedy plant ... and monitor fish responses to restoration activities. , ...
Breaking Biology News(10 mins):Small but speedy: Short plants live in the evolutionary fast lane 2Keeping stem cells strong 2U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4
... January 18, 2011 Using chemical compounds found in a ... ultraviolet light, a Scripps Research Institute team has created a ... biomedical potential. Already, one of the compounds has shown great ... With the report of their work scheduled to ...
... Soy protein,s ability to lower total and ... been extensively studied, but the mechanism whereby soy ... published in the Journal of Clinical Lipidology ... total cholesterol and non-HDL (non-high-density lipoprotein) cholesterol significantly ...
... EAST LANSING, Mich. The downsides of China,s explosive ... now are joined by an upside: Better environmental citizens. ... and leadership when considering environmental behavior in China,s cities. ... Environmental Conservation , scientists at the Center for ...
Cached Biology News:Scripps Research team creates new synthetic compound with HIV-fighting promise 2Scripps Research team creates new synthetic compound with HIV-fighting promise 3New study shows soy protein lowers non-HDL cholesterol significantly more than milk protein 2Big city life may make residents lean toward green, study says 2
Cytofix/Cytoperm Kit 250 Tests...
Cytofix/Cytoperm Plus Kit with GolgiPlug 250 Tests...
Complete PCR kit. Includes: MasterAmp™ Taq DNA Polymerase, 10X PCR Buffer, MasterAmp™ 10X PCR Enhancer, dNTP Mix, 2.5 mM each, 25 mM MgCl2, Enzyme Dilution Buffer, Control Template and Prim...
Mouse monoclonal to OCIL ( Abpromise for all tested applications)....
Biology Products: